Inotiv, Inc. BS50.F Stock
Inotiv, Inc. Price Chart
Inotiv, Inc. BS50.F Financial and Trading Overview
Inotiv, Inc. stock price | 6.1 EUR |
Previous Close | 4.68 EUR |
Open | 4.64 EUR |
Bid | 4.64 EUR x N/A |
Ask | 4.82 EUR x N/A |
Day's Range | 4.64 - 4.64 EUR |
52 Week Range | 3.4 - 25 EUR |
Volume | 21 EUR |
Avg. Volume | 0 EUR |
Market Cap | 121.28M EUR |
Beta (5Y Monthly) | 2.504929 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 64.5 EUR |
BS50.F Valuation Measures
Enterprise Value | 506.94M EUR |
Trailing P/E | N/A |
Forward P/E | 6.9253726 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.2030317 |
Price/Book (mrq) | 0.43629524 |
Enterprise Value/Revenue | 0.849 |
Enterprise Value/EBITDA | 10.843 |
Trading Information
Inotiv, Inc. Stock Price History
Beta (5Y Monthly) | 2.504929 |
52-Week Change | -60.17% |
S&P500 52-Week Change | 20.43% |
52 Week High | 25 EUR |
52 Week Low | 3.4 EUR |
50-Day Moving Average | 5.04 EUR |
200-Day Moving Average | 9.54 EUR |
BS50.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 25.76M |
Float | 20.02M |
Short Ratio | N/A |
% Held by Insiders | 33.06% |
% Held by Institutions | 55.34% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | -57.78% |
Operating Margin (ttm) | -1.86% |
Gross Margin | 26.74% |
EBITDA Margin | 7.82% |
Management Effectiveness
Return on Assets (ttm) | -0.69% |
Return on Equity (ttm) | -77.24% |
Income Statement
Revenue (ttm) | 597.35M EUR |
Revenue Per Share (ttm) | 23.35 EUR |
Quarterly Revenue Growth (yoy) | 7.90% |
Gross Profit (ttm) | 157.21M EUR |
EBITDA | 46.75M EUR |
Net Income Avi to Common (ttm) | -345200992 EUR |
Diluted EPS (ttm) | -12.08 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 24.6M EUR |
Total Cash Per Share (mrq) | 0.96 EUR |
Total Debt (mrq) | 416.93M EUR |
Total Debt/Equity (mrq) | 152.93 EUR |
Current Ratio (mrq) | 1.59 |
Book Value Per Share (mrq) | 10.635 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3818000 EUR |
Levered Free Cash Flow (ttm) | -9704875 EUR |
Profile of Inotiv, Inc.
Country | Germany |
State | IN |
City | West Lafayette |
Address | 2701 Kent Avenue |
ZIP | 47906 |
Phone | 765 463 4527 |
Website | https://www.inotivco.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 2099 |
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services including, computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes, general and genetic toxicology, regulated bioanalysis, biotherapeutics, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes, nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
Q&A For Inotiv, Inc. Stock
What is a current BS50.F stock price?
Inotiv, Inc. BS50.F stock price today per share is 6.1 EUR.
How to purchase Inotiv, Inc. stock?
You can buy BS50.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Inotiv, Inc.?
The stock symbol or ticker of Inotiv, Inc. is BS50.F.
Which industry does the Inotiv, Inc. company belong to?
The Inotiv, Inc. industry is Diagnostics & Research.
How many shares does Inotiv, Inc. have in circulation?
The max supply of Inotiv, Inc. shares is 25.79M.
What is Inotiv, Inc. Price to Earnings Ratio (PE Ratio)?
Inotiv, Inc. PE Ratio is now.
What was Inotiv, Inc. earnings per share over the trailing 12 months (TTM)?
Inotiv, Inc. EPS is -1.2 EUR over the trailing 12 months.
Which sector does the Inotiv, Inc. company belong to?
The Inotiv, Inc. sector is Healthcare.